BASF has completed the second phase of registration for REACH under EU chemical law. REACH stands for the Registration, Evaluation, Authorization and Restriction of Chemicals and represents a fundamental reorganization of chemical law in Europe. The second phase of registration for chemicals with a production volume between 100 and 1,000 metric tons per year ends on May 31. In this phase, BASF submitted around 550 substance dossiers to the European Chemicals Agency (ECHA) – more than any other company. BASF also topped the list of companies in the registration process with around 680 substance dossiers in phase 1. By the end of the final transition period in the year 2018, BASF is expecting a total of approximately 3,500 registrations. 250 employees at BASF are engaged in the implementation of REACH, and the total costs for BASF by the year 2018 will be between €500 million and €550 million.
REACH applies to all substances currently produced in or imported to the EU. They are registered in three phases with data requirements depending on their production volume (substances above 1,000 metric tons per year; substances above 100 metric tons per year; substances above 1 metric ton per year). The implementation of REACH is not limited to registration. Following the registration process, the dossiers that are submitted have to be updated continuously. The risk assessments prepared by the industry are reviewed by ECHA and EU member states competent authorities. These evaluations can result in requests for additional data as well as restrictions or authorization processes. The REACH requirements have to be implemented in the production and business processes. This is intended to ensure the safe handling of chemical substances in Europe
While REACH only applies in Europe, BASF has also set a goal to review all risk assessments worldwide by the year 2020 for substances and mixtures which BASF sells in quantities of more than one ton.
Being a formulator is becoming much more difficult in light of increased regulatory pressures on common raw materials.
Formulators who develop coatings based on oxidatively cured (alkyd) binders face major regulatory obstacles for two key in…